I see that one of the companies you mentioned that the BONU CEO, Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company. In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change. See below:
http://www.icis.com/v2/companies/9146143/rohm+and+haas.html Rohm and Haas | Company Information from ICIS In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.
So, Dow Chemical bought out Rohm and Haas for $78.00 per share. When you click on the old Rohm and Haas website, it takes you to Dow Chemicals website: http://www.rohmhaas.com
For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW: http://www.dow.com/
More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.